SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001445305-13-002882
Filing Date
2013-11-08
Accepted
2013-11-08 16:21:31
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-2013930x10q.htm 10-Q 361481
2 EX-31.1 ljpc-2013930xexhibit311.htm EX-31.1 15852
3 EX-32.1 ljpc-2013930xexhibit321.htm EX-32.1 9810
  Complete submission text file 0001445305-13-002882.txt   2877113

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ljpc-20130930.xml EX-101.INS 360545
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20130930.xsd EX-101.SCH 21180
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20130930_cal.xml EX-101.CAL 27905
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20130930_def.xml EX-101.DEF 119643
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20130930_lab.xml EX-101.LAB 263502
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20130930_pre.xml EX-101.PRE 163668
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 131205012
SIC: 2836 Biological Products, (No Diagnostic Substances)